Summary
The effects of various opioid receptor agonists and antagonists were studied in rabbit caudate nucleus slices preincubated with either [3H]dopamine or [3H] choline, superfused with medium (containing in most experiments the D2 receptor antagonist domperidone) and subjected to electrical field stimulation. The stimulation-evoked [3H]overflow from slices prelabeled with [3H]dopamine (evoked [3H]dopamine release) was significantly reduced by preferential κ-opioid receptor agonists, like U-50,488 H, but not by µ- or δ-opioid receptor selective drugs. Opioid receptor antagonists shifted the concentration/response curve of U-50,488 H to the right (apparent pA2-value of the κ-selective antagonist nor-binaltorphimine: 10.1) and enhanced the evoked dopamine release in the presence of a mixture of peptidase inhibitors.
On the other hand, the [3H]overflow from rabbit caudate nucleus slices prelabeled with [3H]choline (evoked acetylcholine release) remained almost unaffected by any opioid receptor agonist, as long as the presynaptic D2 heteroreceptor was blocked with domperidone: in the absence of domperidone, U-50,488 H exhibited facilitatory effects. For comparison, the effects of the preferential δ-opioid receptor agonist DPDPE was also studied in slices of the rat striatum, where it clearly inhibited the evoked acetylcholine release.
From our data we conlude that in the rabbit caudate nucleus the evoked dopamine release is inhibited by both exogenous and endogenous opioids via presynaptic κ-opioid receptors, whereas the evoked release of acetylcholine is not, or only indirectly (via released dopamine) affected by opioids.
Similar content being viewed by others
References
Beani L, Bianchi C, Siniscalchi A (1982) The effect of naloxone on opioid-induced inhibition and facilitation of acetylcholine release in brain slices. Br J Pharmacol 76:393–401
Birch PJ, Hayes AG, Sheehan MJ, Tyers MB (1987) Norbinaltorphimine: antagonist profile at κ-opioid receptors. Eur J Pharmacol 144:405–408
Di Chiara G, Imperato A (1988) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther 244:1067–1080
Dourmap N, Michael-Titus A, Costentin J (1990) Local enkephalins tonically modulate dopamine release in the striatum: a microdialysis study. Brain Res 524:153–155
Feuerstein TJ, Bammert J, Meyer DK (1987) Endogenous agonists may change the concentration-response curves of exogenous agonists: source of quantitative information about the endogenous tone. Biol Cybern 56:419–429
Feuerstein TJ, Sauermann W, Allgaier C, Singer EA (1993) Mathematical modelling of the autoinhibitory feedback control of noradrenaline release in brain slices. Naunyn-Schmiedeberg's Arch Pharmacol 347:171–179
Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds) Catecholamines. Handbook of experimental pharmacology, XXXIII. Springer, Berlin Heidelberg New York, pp 283–335
Gerfen CR, Baimbridge KG, Thibault J (1987) The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems. J Neurosci 7:3044–3935
Goldstein A (1984) Biology and chemistry of the dynorphin peptides. Peptides 6:95–144
Goldstein A, James IF (1984) Multiple opioid receptors. Criteria for identification and classification. Trends Pharmacol Sci 5:503–505
Herdon H, Strupish J, Nahorski SR (1985) Differences between the release of radiolabelled and endogenous dopamine from superfused rat brain slices: effects of depolarizing stimuli, amphetamine and synthesis inhibition. Brain Res 348:309–320
Hertting G, Zumstein A, Jackisch R, Hoffmann I, Starke K (1980) Modulation by endogenous dopamine of the release of acetylcholine in the caudate nucleus of the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 315:111–117
Illes P (1989) Modulation of transmitter and hormone release by multiple neuronal opioid receptors. Rev Physiol Biochem Pharmacol 112:139–233
Illes P, Jackisch R (1991) Modulation of catecholamine release in the central nervous system by multiple opioid receptors. In: Almeida OFX, Shippenberg TS (eds) Neurobiologie of opioids. Springer, Berlin Heidelberg New York, pp 213–225
Jackisch R (1991) Regulation of neurotransmitter release by opiates and opioid peptides in the central nervous system. In: Feigenbaum J, Hanani M (eds) Presynaptic regulation of neurotransmitter release: a handbook, vol 2, Freund, Tel Aviv, pp 551–592
Jackisch R., Geppert M, Brenner AS, Illes P (1986a) Presynaptic opioid receptors modulating acetylcholine release in the hippocampus of the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 332:156–162
Jackisch R, Geppert M, Illes P (1986b) Characterization of opioid receptors modulating noradrenaline release in the hippocampus of the rabbit. J Neurochem 46:1802–1810
Jackisch R, Hotz H, Hertting G (1991) Modulation of dopamine and acetylcholine release in the rabbit caudate nucleus by opioids: receptor type and interaction with autoreceptors. In: Langer SZ, Galzin AM, Costentin J (eds) Advances in the biosciences, vol 82, Presynaptic receptors and neuronal transporters. Pergamon, Oxford, pp 103–104
Lubetzki C, Chesselet MF, Glowinski J (1982) Modulation of dopamine release in rat striatal slices by delta opiate agonists. J Pharamacol Exp Ther 222:435–440
Mansour, A, Khachaturian H, Lewis ME, Akil H, Watson SJ (1988) Anatomy of CNS opioid receptors. Trends Neurosci 11:308–314
Mulder AH, Schoffelmeer ANM (1993) Multiple opioid receptors and presynaptic modulation of neurotransmitter release in the brain. In: Herz A (ed) Handbook experimental pharmacology 104/I, Opioids I. Springer, Berlin Heidelberg New York, pp 125–144
Mulder AH, Wardeh G, Hogenboom F, Frankhuyzen AL (1984) κ- and δ-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature 308:278–280
Portoghese PS, Lipkowski AW, Takemori AE (1987) Binaltorphimine and nor-binaltorphimine, potent and selective κ-opioid receptor antagonists. Life Sci 40:1287–1292
Racké K, Ritzel H, Trapp B. and Muscholl E (1982) Doparninergic modulation of evoked vasopressin release from the isolated neurohypophysis of the rat. Possible involvement of endogenous opioids. Naunyn-Schmiedeberg's Arch Pharmacol 319:56–65
Singer EA (1988) Transmitter release from brain slices elicited by single pulses: a powerful method to study presynaptic mechanisms. Trends Pharmacol Sci 9:274–276
Starke K, Reimann W Zumstein A, Hertting G (1978) Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 305:27–36
Traynor J (1989) Subtypes of the κ-opioid receptor: fact or fiction? Trends Pharmacol Sci 10:52–53
Turner AJ, Matsas R, Kenny AJ (1985) Are there neuropeptide-specific peptidases? Biochem Pharmacol 34:1347–1356
Wallenstein S, Zucker CL, Fleiss JL (1980) Some statistical methods useful in circulation research. Circ Res 47:1–9
Werling LL, Frattali A, Portoghese PS, Takemori AE, Cox BM (1988) Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs. J Pharmacol Exp Ther 246:282–286
Wichmann T, Starke K (1990) Modulation by muscarine and opioid receptors of acetylcholine release in slices from striato-striatal grafts in the rat. Brain Res 510:296–302
Wood PL, Stotland LM (1980) Actions of enkephalin, µ and partial agonist analgesics on acetylcholine turnover in rat brain. Neuropharmacol 19:975–982
Wood PL, Stotland M, Richard JW, Rackham A (1980) Actions of mu, kappa, sigma delta and agonist/antagonist opiates on striatal dopaminergic function. J Pharmacol Exp Ther 215:697–703
Author information
Authors and Affiliations
Additional information
Correspondence to R. Jackisch at the above address
Rights and permissions
About this article
Cite this article
Jackisch, R., Hotz, H. & Hertting, G. No evidence for presynaptic opioid receptors on cholinergic, but presence of κ-receptors on dopaminergic neurons in the rabbit caudate nucleus: involvement of endogeneous opioids. Naunyn-Schmiedeberg's Arch Pharmacol 348, 234–241 (1993). https://doi.org/10.1007/BF00169150
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00169150